Uganda, US pharma giant Pfizer enter partnership to improve access to top cancer drugs
The Uganda Cancer Institute (UCI) has partnered with Pfizer, a major American pharmaceutical company, through its 'Accord for a Healthier World' initiative. This collaboration aims to significantly improve access to affordable, high-quality cancer medicines in Uganda, including newer, expensive treatments previously unavailable.
Why it matters
This partnership is a major milestone for public health in Uganda, promising to make life-saving cancer drugs accessible and affordable for patients who previously lacked access. It demonstrates a model for addressing healthcare disparities in low-income countries through corporate social responsibility and international collaboration.
Uganda Cancer Institute (UCI) has partnered with American pharmaceutical and biotechnology company Pfizer to improve access to cancer medicines at affordable prices in the East African country.
Speaking at the launch of Pfizer’s Accord for a Healthier World initiative in Kampala on Thursday, State Minister for Primary Healthcare Dr Charles Ayume described the partnership as a major milestone that could eventually lead to local manufacturing of cancer medicines.
“It is a big sigh of relief when Pfizer, which is among the top five pharmaceuticals in the world, steps forward and basically it's looking at giving us medicines at non-profit cost, zero profit,” he said.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in